BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chung WC, Zhou X, Atfi A, Xu K. PIK3CG Is a Potential Therapeutic Target in Androgen Receptor-Indifferent Metastatic Prostate Cancer. Am J Pathol 2020;190:2194-202. [PMID: 32805234 DOI: 10.1016/j.ajpath.2020.07.013] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Shu L, Liu S, Tao Y. Development and validation of a prognosis prediction model based on 18 endoplasmic reticulum stress-related genes for patients with lung adenocarcinoma. Front Oncol 2022;12:902353. [DOI: 10.3389/fonc.2022.902353] [Reference Citation Analysis]
2 Yu B, Wang M, Xu H, Gao R, Zhu Y, Ning H, Dai X, Silvestre S. Investigating the Role of Dahuang in Hepatoma Treatment Using Network Pharmacology, Molecular Docking, and Survival Analysis. BioMed Research International 2022;2022:1-15. [DOI: 10.1155/2022/5975223] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Hobbs GA, Der CJ. KRASG12R-Independent Macropinocytosis in Pancreatic Cancer. Subcell Biochem 2022;98:205-21. [PMID: 35378710 DOI: 10.1007/978-3-030-94004-1_11] [Reference Citation Analysis]
4 Zeng C, Yuan G, Hu Y, Wang D, Shi X, Zhu D, Hu A, Meng Y, Lu J. Repressing phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma by microRNA-142-3p restrains the progression of hepatocellular carcinoma. Bioengineered 2022;13:1491-506. [PMID: 34986757 DOI: 10.1080/21655979.2021.2020549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]